Singota Solutions
Private Company
Total funding raised: $14.5M
Overview
Singota Solutions is a specialized CDMO focused on accelerating early-phase injectable drug development and manufacturing. It differentiates itself through a flexible, single-site model, proprietary gloveless robotic aseptic filling technology (SA25), and comprehensive service integration from development through cold chain storage. The company targets pharmaceutical, biotech, and animal health clients seeking speed and reliability for small-batch clinical trial materials. Its strategy is built on technological innovation, operational excellence, and a collaborative project management structure.
Technology Platform
Gloveless, robotic SA25 Aseptic Filling system for small-batch parenterals, integrated with GMP analytical labs and cold chain supply chain management.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Singota competes in the injectables CDMO space against large global players (e.g., Lonza, Catalent) and smaller niche providers. Its primary differentiation is the combination of specialized small-batch focus, proprietary robotic aseptic filling (SA25), and integrated, agile service from a single site. Competition is based on technology, speed, quality, reliability, and price.